Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

East Windsor, New Jersey 08520


Purpose:

12 weeks open label with Otezla® and NUVB, followed by 6 month double blind Otezla® (apremilast) or placebo to subjects who obtain PASI 75 at week 12 of phototherapy


Study summary:

Primary Objective: To evaluate the effectiveness of Otezla (apremilast®) in promoting maintenance of response in those subjects who obtained PASI-75 at week 12 of phototherapy.


Criteria:

Inclusion Criteria: Subjects must meet the following criteria to be enrolled in this study: 1. Male or female adult ≥ 18 years of age; 2. Diagnosis of chronic plaque-type 3. Moderate to severe plaque type psoriasis as defined at baseline by: - PASI score of 12 or greater, - PGA score of 3 or greater - BSA affected by plaque-type psoriasis of 10% or greater, 4. Able and willing to give written informed consent prior to performance of any study-related procedures Exclusion Criteria: Subjects who meet any of the following criteria will be excluded from participation in this study: 1. Forms of psoriasis other than chronic plaque-type (e.g., pustular, erythrodermic, and/or guttate psoriasis) or drug induced psoriasis 2. Subjects with previous exposure to apremilast 3. Malignancy or history of malignancy, except for: - treated [ie, cured] basal cell or squamous cell in situ skin carcinomas; - treated [ie, cured] malignancy with no evidence of recurrence within the previous 5 years.


NCT ID:

NCT02412644


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

East Windsor, New Jersey 08520
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.